Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aluminum Exposure From Vaccines and Diet.

JAMA·2026
Same author

Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.

JAMA·2025
Same author

Bivalent Covid-19 Vaccines. Reply.

The New England journal of medicine·2023
Same author

COVID-19 Vaccines in Young Children-Reassuring Evidence for Parents.

JAMA pediatrics·2023
Same author

Bivalent Covid-19 Vaccines - A Cautionary Tale.

The New England journal of medicine·2023
Same author

Covid-19 Boosters - Where from Here?

The New England journal of medicine·2022

Related Experiment Video

Updated: Feb 16, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.4K

Challenges to Developing a Rotavirus Vaccine.

Paul A Offit1

  • 1Division of Infectious Diseases, The Children's Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania , Philadelphia, Pennsylvania.

Viral Immunology
|December 22, 2017
PubMed
Summary

Rotavirus causes severe gastroenteritis globally, especially in infants. This content reviews the history and challenges in developing a rotavirus vaccine to combat this significant public health threat.

Keywords:
gastroenteritisrotavirusvaccine development

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.4K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Related Experiment Videos

Last Updated: Feb 16, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.4K
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.4K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • Rotavirus is a leading cause of severe gastroenteritis in infants and young children worldwide.
  • It poses a significant mortality risk in developing nations.
  • Prior to vaccine introduction, rotavirus infections caused millions of cases annually in the United States.

Observation:

  • The global burden of rotavirus-induced gastroenteritis is substantial, particularly impacting vulnerable populations.
  • Historical data highlights the extensive disease burden necessitating effective interventions.
  • The development of a rotavirus vaccine has been a critical goal in pediatric infectious disease control.

Findings:

  • The history of rotavirus vaccine development is marked by significant scientific and logistical challenges.
  • Overcoming these hurdles has been essential for creating effective preventative measures.
  • The licensure of rotavirus vaccines represents a major advancement in public health.

Implications:

  • Successful rotavirus vaccine development has drastically reduced disease incidence and mortality.
  • Continued research and implementation are crucial for global health equity.
  • Vaccination strategies are key to controlling rotavirus outbreaks and protecting child populations.